Search Results - "STIVELMAN, J. C"

Iron status in patients receiving erythropoietin for dialysis-associated anemia by Van Wyck, David B., Stivelman, John C., Ruiz, Joaquin, Kirlin, Linda F., Katz, Murray A., Ogden, David A.

“…Iron status in patients receiving erythropoietin for dialysis-associated anemia. Adequate body iron stores are crucial to assuring rapid and complete response…”
Get full text

Safety and efficacy of low-dose subcutaneous erythropoietin in hemodialysis patients by PARKER, K. P, MITCH, W. E, STIVELMAN, J. C, MACON, E. J, BAILEY, J. L, SANDS, J. M

“…Anemia in hemodialysis patients is effectively treated by intravenous (IV) injections of recombinant human erythropoietin (rHuEPO) at each dialysis session…”
Get full text

Risk factors and mortality associated with calciphylaxis in end-stage renal disease by Mazhar, A. Rauf, Johnson, Richard J., Gillen, Daniel, Stivelman, John C., Ryan, Michael J., Davis, Connie L., Stehman-Breen, Catherine O.

“…Risk factors and mortality associated with calciphylaxis in end-stage renal disease. We conducted a case control study to determine risk factors and mortality…”
Get full text

Benefits of anaemia treatment on cognitive function by STIVELMAN, John C

“…The role of anaemia in the pathogenesis of abnormal cognitive function in haemodialysis patients is only partly understood. Several contemporary studies have…”
Get full text

Resistance to recombinant human erythropoietin therapy: a real clinical entity? by Stivelman, J C

“…Recombinant human erythropoietin (r-HuEPO; EPOGEN [epoetin alfa], AMGEN Inc, Thousand Oaks, CA) has proven to be an effective agent in treating the anemia of…”
Get more information

Rapid sample preparation for determination of iron in tissue by closed-vessel digestion and microwave energy by Van Wyck, D B, Schifman, R B, Stivelman, J C, Ruiz, J, Martin, D

“…We developed a rapid acid-digestion method for preparing tissue samples for iron determination. Specimens were digested in nitric acid and hydrogen peroxide…”
Get more information

Dialysis survival in a large inner-city facility: a comparison to national rates by Stivelman, J C, Soucie, J M, Hall, E S, Macon, E J

“…Impoverished patients may represent a high-risk population with poor survival. With 1993 U.S. Renal Data System survival tables (to adjust the risk of death…”
Get full text

Injectable medications for hemodialysis patients by Stivelman, J C

“…Increasing use of medications designed specifically for intravenous administration during hemodialysis has dramatically improved the treatment of many comorbid…”
Get more information

Iron overload and mobilization in long-term hemodialysis patients by Hakim, R M, Stivelman, J C, Schulman, G, Fosburg, M, Wolfe, L, Imber, M J, Lazarus, J M

“…Iron overload from repeated transfusions of RBCs in long-term hemodialysis patients is a problem of increasing clinical significance. We report on the…”
Get more information

Transdermal Androgen Therapy to Augment EPO in the Treatment of Anemia of Chronic Renal Disease by Brockenbrough, Andrew T., Dittrich, Mary O., Page, Stephanie T., Smith, Ted, Stivelman, John C., Bremner, William J.

“…Background: Hypogonadism and anemia are common comorbid conditions in dialysis patients. Testosterone replacement may improve such clinical parameters as…”
Get full text

Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia? by Eschbach, Joseph W., Varma, Ashok, Stivelman, John C.

“…An increasing number of reports documenting resistance to human recombinant erythropoietin (rHuEPO) therapy are challenging the concept that erythropoietin…”
Get full text